Skip to main content

Animations

MJFF Publications

3191 - 3200 of 6295 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2023
  • 2017
  • 2011
  • 2020
  • 2018
  • 2016
  • 2024
  • 2017
  • Summary Details
    OPEN
    Title: Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT images
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2021.104312
    Best OA location URL:
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Structural basis for the specificity of PPM1H phosphatase for Rab GTPases
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.15252/embr.202152675
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Senescent Schwann cells induced by aging and chronic denervation impair axonal regeneration following peripheral nerve injury
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202317907
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0189161
    Citation Count: 162
  • Summary Details
    OPEN
    Title: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 Cases
    Journal Name: Sleep Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2011/468952
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20200458
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2
    Journal Name: Neurochemical Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 979
  • Summary Details
    OPEN
    Title: The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae056
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20170802
    Citation Count: 150
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.